ENOV
EnovisCNYSE / Health Care Equipment & Services
Last Price
At close
2026-06-03
Current thesis
The bull case is that investors eventually focus on the underlying operating picture rather than the goodwill write-down: FY2025 organic growth was 6%, Recon remained the stronger segment, and 2026 guidance implies another year of growth and EBITDA expansion if execution holds [#8-K-2026-02-26].
Posture
Mixed
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite, 7D delta +12.8.
What can break
Execution miss versus 2026 organic growth, EBITDA, or EPS guidance could quickly reopen downside.
Momentum
37
Value
59
Sentiment
59
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $28.00 · Bull $36.00 · Bear $18.00
Data freshness
Prices
As of 2026-06-03
Fundamentals
As of 2026-06-02 • Vendor: Data Vendor v1
Scores
As of 2026-06-03 • Model: HYBRID_IC_RP
AI Memo
As of 2026-04-22 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-06-03
Investment thesis
As of 2026-06-03
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Neutral
Target $44.70
Why
Momentum37 · Δ7d -24.3
Value59 · Δ7d +0.8
Sentiment59 · Δ7d +12.8
So what
Balanced signals (Net Neutral). Wait for confirmation before sizing up.
Lead driver: Sentiment · See AI snapshot
Momentum
37
34% active weight
Current posture
7d trendSoftening
Δ7d
-24.3
Δ21d
-19.4
Value
59
32% active weight
Current posture
7d trendFlat
Δ7d
+0.8
Δ21d
+1.5
Sentiment
59
33% active weight
Current posture
7d trendImproving
Δ7d
+12.8
Δ21d
+26.9
Why this grade
Composite grade C. Momentum 37.5 / Value 58.7 / Sentiment 59.3
Fundamentals (TTM)As of 2026-06-02
Fundamentals (TTM)
As of 2026-06-02
Market Cap
$1.26B
Beta
1.29
Shares Out
57.19M
P/E (TTM) · Derived
-1.1
P/S (TTM)
0.69
P/FCF (TTM)
67.85
Rev YoY
+8.6%
EPS YoY
-1547.0%
Gross Margin
+57.2%
Op Margin
-57.7%
Net Debt
$1.28B
Current Ratio
2.22
As of 2026-06-03 • Updated nightlySource: Internal modelMethodology